Therefore, we need more clinical studies and observations to confirm the alterations in IL-22 levels in patients with PCOS, as well as more effort to investigate the underlying mechanisms of the differences in IL-22 levels among various metabolic diseases. Here, IL22 is linked to polycystic ovary syndrome.